Project Details
Projekt Print View

The role of HDAC3 in Notch signal transduction

Subject Area Cell Biology
Biochemistry
Developmental Biology
Hematology, Oncology
Term from 2017 to 2022
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 393040308
 
Final Report Year 2023

Final Report Abstract

Aberrant Notch signaling plays a pivotal role in T-cell acute lymphoblastic leukemia (T- ALL) and chronic lymphocytic leukemia (CLL). Amplitude and duration of the Notch response is controlled by ubiquitin-dependent proteasomal degradation of the Notch1 intracellular domain (NICD1), a hallmark of the leukemogenic process. In this project we showed that HDAC3 controls NICD1 acetylation levels directly affecting NICD1 protein stability. Either genetic loss-of-function of HDAC3 or nanomolar concentrations of HDAC inhibitor apicidin lead to downregulation of Notch target genes accompanied by a local reduction of histone acetylation. Importantly, an acetylation-deficient NICD1 mutant is more stable but biologically less active. Collectively, these data show a new HDAC3- and acetylation-dependent mechanism that may be exploited to treat Notch1- dependent leukemias.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung